These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19197281)

  • 21. Nephropathy in remnant kidneys: pathological proteinuria after unilateral nephrectomy.
    Lent V; Harth J
    J Urol; 1994 Aug; 152(2 Pt 1):312-6. PubMed ID: 8015059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteinuria: changes and mechanisms in toxic nephropathies.
    Bernard A; Lauwerys RR
    Crit Rev Toxicol; 1991; 21(5):373-405. PubMed ID: 1741950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of renal NaCl retention in proteinuric disease.
    Svenningsen P; Friis UG; Versland JB; Buhl KB; Møller Frederiksen B; Andersen H; Zachar RM; Bistrup C; Skøtt O; Jørgensen JS; Andersen RF; Jensen BL
    Acta Physiol (Oxf); 2013 Mar; 207(3):536-45. PubMed ID: 23216619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered renal hemodynamics is associated with glomerular lipid accumulation in obese Dahl salt-sensitive leptin receptor mutant rats.
    McPherson KC; Shields CA; Poudel B; Johnson AC; Taylor L; Stubbs C; Nichols A; Cornelius DC; Garrett MR; Williams JM
    Am J Physiol Renal Physiol; 2020 Apr; 318(4):F911-F921. PubMed ID: 32068459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteinuria: detection and role in native renal disease progression.
    Gorriz JL; Martinez-Castelao A
    Transplant Rev (Orlando); 2012 Jan; 26(1):3-13. PubMed ID: 22137726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
    Lin SL; Chen YM; Chiang WC; Wu KD; Tsai TJ
    Am J Kidney Dis; 2008 Sep; 52(3):464-74. PubMed ID: 18617301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Proteinuria].
    Ado MA; Belikova TN
    Klin Med (Mosk); 1974 Apr; 52(4):24-7. PubMed ID: 4459563
    [No Abstract]   [Full Text] [Related]  

  • 29. Biophysiology of glomerular filtration and proteinuria.
    Kanwar YS
    Lab Invest; 1984 Jul; 51(1):7-21. PubMed ID: 6376945
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanisms of proteinuria in noninflammatory glomerular diseases.
    Savin VJ
    Am J Kidney Dis; 1993 Apr; 21(4):347-62. PubMed ID: 8465812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in susceptibility to develop parameters of diabetic nephropathy in four mouse strains with type 1 diabetes.
    Franzén S; Friederich-Persson M; Fasching A; Hansell P; Nangaku M; Palm F
    Am J Physiol Renal Physiol; 2014 May; 306(10):F1171-8. PubMed ID: 24623147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanism by which proteinuria exacerbates kidney diseases].
    Sugisaki T
    Nihon Naika Gakkai Zasshi; 2001 Jul; 90(7):1292-8. PubMed ID: 11519110
    [No Abstract]   [Full Text] [Related]  

  • 33. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial.
    Tonelli M; Jose P; Curhan G; Sacks F; Braunwald E; Pfeffer M;
    BMJ; 2006 Jun; 332(7555):1426. PubMed ID: 16714328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy.
    Fujino T; Hasebe N
    BMC Nephrol; 2016 Nov; 17(1):179. PubMed ID: 27855638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy.
    Luna E; Cerezo I; Macias R; Villa J; Martinez C; Cubero J; Martinez R; Ferreira F; García C
    Transplant Proc; 2011; 43(6):2187-90. PubMed ID: 21839229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of nephrin and a new proteinuria-associated protein expression in human renal diseases.
    Wang SX; Rastaldi MP; Pätäri A; Ahola H; Heikkilä E; Holthöfer H
    Kidney Int; 2002 Jan; 61(1):141-7. PubMed ID: 11786094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the antiproteinuric effect of dipyridamole hemodynamically mediated?
    de Jong PE; van der Meer J; van der Hem GK; de Zeeuw D
    Nephron; 1988; 50(4):292-4. PubMed ID: 3070413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indices of kidney dysfunction and discharge outcomes in hospitalized stroke patients without known renal disease.
    Ovbiagele B; Sanossian N; Liebeskind DS; Kim D; Ali LK; Pineda S; Saver JL
    Cerebrovasc Dis; 2009; 28(6):582-8. PubMed ID: 19844098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sirolimus therapy of focal segmental glomerulosclerosis is associated with nephrotoxicity.
    Cho ME; Hurley JK; Kopp JB
    Am J Kidney Dis; 2007 Feb; 49(2):310-7. PubMed ID: 17261434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.
    Vogelbacher R; Wittmann S; Braun A; Daniel C; Hugo C
    Transplantation; 2007 Dec; 84(11):1492-9. PubMed ID: 18091526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.